Inspire Medical Systems Stock EBITDA
| INSP Stock | USD 244.00 2.34 0.97% |
Inspire Medical Systems fundamentals help investors to digest information that contributes to Inspire Medical's financial success or failures. It also enables traders to predict the movement of Inspire Stock. The fundamental analysis module provides a way to measure Inspire Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inspire Medical stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -40.3 M | -42.3 M |
Inspire | EBITDA |
Inspire Medical Systems Company EBITDA Analysis
Inspire Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Inspire Medical EBITDA | (40.27 M) |
Most of Inspire Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inspire Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Inspire EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Inspire Medical is extremely important. It helps to project a fair market value of Inspire Stock properly, considering its historical fundamentals such as EBITDA. Since Inspire Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Inspire Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Inspire Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Inspire Ebitda
According to the company disclosure, Inspire Medical Systems reported earnings before interest,tax, depreciation and amortization of (40.27 Million). This is 104.59% lower than that of the Health Care Technology sector and 106.27% lower than that of the Health Care industry. The ebitda for all United States stocks is 101.03% higher than that of the company.
Inspire EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inspire Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inspire Medical could also be used in its relative valuation, which is a method of valuing Inspire Medical by comparing valuation metrics of similar companies.Inspire Medical is currently under evaluation in ebitda category among related companies.
Inspire Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Inspire Medical from analyzing Inspire Medical's financial statements. These drivers represent accounts that assess Inspire Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Inspire Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.8B | 4.9B | 6.3B | 7.1B | 6.0B | 6.3B | |
| Enterprise Value | 1.8B | 4.7B | 6.1B | 6.6B | 5.8B | 6.1B |
Inspire Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Inspire Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Inspire Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Inspire Medical's value.| Shares | Jpmorgan Chase & Co | 2023-12-31 | 631.9 K | Westfield Capital Management Company, Lp | 2023-12-31 | 545.6 K | Macquarie Group Ltd | 2023-12-31 | 538.6 K | State Street Corporation | 2023-12-31 | 531.2 K | Franklin Resources Inc | 2023-12-31 | 514 K | Ameriprise Financial Inc | 2023-12-31 | 491.3 K | Federated Hermes Inc | 2023-12-31 | 453.3 K | Geode Capital Management, Llc | 2023-12-31 | 444.8 K | Fred Alger Management, Llc | 2023-12-31 | 405.9 K | Fmr Inc | 2023-12-31 | 3.3 M | Vanguard Group Inc | 2023-12-31 | 2.9 M |
Inspire Fundamentals
| Return On Equity | -0.0396 | ||||
| Return On Asset | -0.0405 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 6.71 B | ||||
| Shares Outstanding | 30.3 M | ||||
| Shares Owned By Insiders | 1.90 % | ||||
| Shares Owned By Institutions | 98.10 % | ||||
| Number Of Shares Shorted | 2.31 M | ||||
| Price To Earning | 15.29 X | ||||
| Price To Book | 12.26 X | ||||
| Price To Sales | 11.24 X | ||||
| Revenue | 624.8 M | ||||
| Gross Profit | 341.74 M | ||||
| EBITDA | (40.27 M) | ||||
| Net Income | (21.15 M) | ||||
| Cash And Equivalents | 196.32 M | ||||
| Cash Per Share | 7.10 X | ||||
| Total Debt | 24.85 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 5.62 X | ||||
| Book Value Per Share | 19.37 X | ||||
| Cash Flow From Operations | 24.65 M | ||||
| Short Ratio | 4.93 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Price To Earnings To Growth | (2.57) X | ||||
| Target Price | 254.88 | ||||
| Number Of Employees | 1.01 K | ||||
| Beta | 1.4 | ||||
| Market Capitalization | 7.32 B | ||||
| Total Asset | 676.81 M | ||||
| Retained Earnings | (345.42 M) | ||||
| Working Capital | 515.63 M | ||||
| Current Asset | 167.55 M | ||||
| Current Liabilities | 64.84 M | ||||
| Net Asset | 676.81 M |
About Inspire Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inspire Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inspire Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inspire Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Inspire Medical Investors Sentiment
The influence of Inspire Medical's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Inspire. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Inspire Medical's public news can be used to forecast risks associated with an investment in Inspire. The trend in average sentiment can be used to explain how an investor holding Inspire can time the market purely based on public headlines and social activities around Inspire Medical Systems. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Inspire Medical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Inspire Medical's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Inspire Medical's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Inspire Medical.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Inspire Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Inspire Medical's short interest history, or implied volatility extrapolated from Inspire Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Inspire Medical Piotroski F Score and Inspire Medical Altman Z Score analysis. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Inspire Stock analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Inspire Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inspire Medical. If investors know Inspire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inspire Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.682 | Earnings Share (0.72) | Revenue Per Share 21.323 | Quarterly Revenue Growth 0.396 | Return On Assets (0.04) |
The market value of Inspire Medical Systems is measured differently than its book value, which is the value of Inspire that is recorded on the company's balance sheet. Investors also form their own opinion of Inspire Medical's value that differs from its market value or its book value, called intrinsic value, which is Inspire Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inspire Medical's market value can be influenced by many factors that don't directly affect Inspire Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inspire Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspire Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inspire Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.